SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-711049
Filing Date
2016-09-15
Accepted
2016-09-15 16:47:02
Documents
6
Period of Report
2016-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d230556d8k.htm 8-K 17589
2 EX-1.1 d230556dex11.htm EX-1.1 168930
3 EX-5.1 d230556dex51.htm EX-5.1 9746
4 EX-99.1 d230556dex991.htm EX-99.1 7291
5 GRAPHIC g230556g0915075508597.jpg GRAPHIC 1914
6 GRAPHIC g230556g14z49.jpg GRAPHIC 7799
  Complete submission text file 0001193125-16-711049.txt   218307
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 161887580
SIC: 2834 Pharmaceutical Preparations